Form 6-K AURORA CANNABIS INC For: May 20
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall St tumbles on tech selloff as concerns about hawkish Fed, AI spending mount
- SpaceX extends losses after $600 billion wipeout, tech stocks slide again
- Oil steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Aurora Cannabis (ACB:CN) (ACB) PT Raised to Cdn$27 at Cantor Fitzgerald; Positive on Reliva Deal
May 21, 2020 8:18 AM EDTCantor Fitzgerald analyst Pablo Zuanic raised the price target on Aurora Cannabis (ACB:CN) (NYSE: ACB) to Cdn$27.00 (from Cdn$22.00) while maintaining an Overweight rating after the company agreed to acquire Reliva.
The analyst commented, "ACB proved last Thursday (5/14) that it is making great strides with its reset (divestitures, cost cuts, cash flow improvement), and played down the risk of further dilution. Over the past 90 days into the print, the stock had been... More
